Harmony Biosciences Holdings (HRMY) Intangibles (2019 - 2026)

Harmony Biosciences Holdings (HRMY) has 8 years of Intangibles data on file, last reported at $83.5 million in Q1 2026.

• For the quarter ending Q1 2026, Intangibles fell 61.18% year-over-year to $83.5 million; the trailing twelve-month figure through Mar 2026 stood at $83.5 million (down 61.18% YoY), and the FY2025 full-year result was $89.4 million, down 21.05% from the prior year.
• Intangibles fell to $83.5 million in Q1 2026, from $89.4 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $215.0 million in Q3 2022 to a low of $83.5 million in Q1 2026.
• A 5-year average of $175.9 million and a median of $215.0 million in 2022 frame the typical range for Intangibles.
• Across the five-year window, Intangibles soared 63.94% in 2025 and plunged 61.18% in 2026, its largest moves.
• Tracing HRMY's Intangibles over 5 years: stood at $215.0 million in 2022, then plunged by 36.23% to $137.1 million in 2023, then fell by 17.39% to $113.3 million in 2024, then decreased by 21.05% to $89.4 million in 2025, then slipped by 6.67% to $83.5 million in 2026.
• Business Quant data shows HRMY's Intangibles at $83.5 million in Q1 2026, $89.4 million in Q4 2025, and $215.0 million in Q3 2025.